ABSTRACT. The effect of all-trans retinoic acid (ATRA) on the expression of α-smooth muscle actin (α-SMA) in rats with pulmonary arterial hypertension (PAH) was studied, and the mechanism of the effect of ATRA on PAH was proposed. Thirty male SD rats were randomly divided into normal control, monocrotaline (MCT) model, and ATRA [30 mg/(kg.day)] intervention groups (N = 10 each). The mean pulmonary arterial pressure was recorded. Right ventricular hypertrophy index (RVHI) was calculated (weight of right ventricle: total weight of left ventricle and interventricular septum). The percentages of wall thickness of pulmonary arteriole (WT) to external diameter of artery (WT%) and vascular wall area (WA) to total vascular area (WA%) were determined. Real-time fluorescencebased quantitative PCR and western blot analyses were employed to detect the α-SMA mRNA and protein expressions. The mean pulmonary arterial pressure, RVHI, WT%, and WA% were all obviously higher in the model group than in the control and intervention groups. The values of these indicators in the intervention group were also higher than those in the control group (P < 0.01). The mRNA and protein expression levels of 14309 Effects of ATRA on α-SMA in PAH rats ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (4): 14308-14313 (2015) α-SMA were significantly higher in the lung tissue of model rats than those in the control and intervention groups. However, the intervention group showed no statistically significant differences in α-SMA mRNA and protein expression levels compared to the control (P < 0.05). ATRA inhibited the α-SMA mRNA and protein expressionin the lung tissues of rats with MCTinduced PAH, and could be used to treat PAH.
INTRODUCTION
Pulmonary arterial hypertension (PAH) is an increase in blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, which can result in right ventricular failure and death. Retinoids are natural and synthetic derivatives of vitamin A, and play an important role in cell proliferation and differentiation. Many biological functions are associated with vascular reconstruction in PAH. PAH was induced in rats using monocrotaline (MCT) to observe the effect of ATRA on PAH. In this study, the levels of expression of α-smooth muscle actin (α-SMA) were detected in lung tissues, and the mechanism with which ATRA affects the prevention and treatment of PAH was analyzed.
MATERIAL AND METHODS

Experimental animals, reagents and instruments
Healthy male Sprague-Dawl (SD) rats weighing 220 ± 20 g were provided by the Experimental Animal Center of the Medical School of Jiangsu University. The reagents utilized in this study included MCT (Sigma-Aldrich, USA), ATRA (Northeast Pharmaceutical Co., Ltd.), TRIzol reagent (Invitrogen, USA), reverse transcription kit (Toyoba, Shanghai, China) , and the fluorescence quantitative kit (Toyoba). α-SMA mRNA primers were synthesized by Sangon Biotech (Shanghai, China). The Medlab-E Biology Gathering System used in this study was manufactured by the Nanjing Meiyi Technology Co., Ltd.
Model establishment and grouping
Thirty SD rats were randomly divided into the control, model, and intervention groups, with 10 rats in each group. MCT was injected into the model and intervention groups to induce PAH. MCT was dissolved in appropriate quantities of 0.5 N HCl, and the pH value was adjusted to 7.4 using 0.5 N NaOH. Intraperitoneal injection (60 mg/kg) was performed once for the model and intervention groups. Equal volumes of normal saline was injected into rats of the control group. Gastric lavage was performed once every day between days 0 and 28 of the experiment using ATRA (30 mg/kg.day) and normal saline, for the intervention and model groups, respectively.
Preparation of pulmonary artery catheter
PV-1 tube (length approximately 15 cm) was used as the artery catheter. The tube was heated using a flame at a distance of 1 cm from one end, in order to make it bend towards the heat (under the effect of gravity). A smooth arc was obtained with a radius of approximately 3 cm, and the curvature comparable to that of the right ventricular wall and pulmonary artery. The catheter was marked 3-4 cm from one end in order to track the position of the catheter.
Measurement of mean pulmonary arterial pressure and RVHI
After treatment for 28 days, the rats were anesthetized by intraperitoneal injection of 3% sodium pentobarbital (30 mg/kg), and immobilized in the supine position. An incision was made to the right of the midline of the neck to expose and dissociate the right external jugular vein. The pulmonary artery catheter, filled with heparin saline, was inserted into the right external jugular vein. The arc was made to point downwards during the insertion. Upon reaching the heart, the catheter was rotated towards the left and advanced further. Following the increase in the baseline pressure and the appearance of the pulmonary artery pressure waveform on the physiological grapher, the catheter was retracted by about 1 cm. The catheter was advanced again until the mean pulmonary artery pressure waveform was observed (Wang et al., 2000; Wang, 2003) . The heart was harvested after measurement of this waveform. The atria were removed, and the left ventricle, right ventricle, and interventricular septum were separated. The tissues were washed with iced saline, dried with filter paper, and weighed. RVHI was measured.
Preparation of tissue specimens and detection of indicators
The rats were sacrificed. The lower lobe of the right lung was harvested and fixed in 10% formaldehyde. The tissues were made into paraffin sections and subjected to hematoxylinEosin (HE) staining. The pulmonary arterioles, with s diameter of 50-100 µm, were then randomly selected in each field of view. The wall thickness (WT) and external diameter (ED) was measured using a pathological image analysis software. WT% (WT% = 2 x (WT/ED) x 100) and WA% [WA% = (TA-LA)/TA x 100] were calculated.
Detection of mRNA and protein expression of α-SMA in lung tissues by fluorescent quantitative RT-PCR
The lower lobe of the left lung, weighing 0.1 g, was harvested for total RNA extraction by the one-step method, according to the TRIzol reagent manufacturer protocols. cDNA reverse transcription was performed for the cytokines using 1 mL of the RNA extracted from each sample, according to the standard protocols provided in the reverse transcription kit. The specific primers of α-SMA (with primers for beta-actin acting as the internal reference) were used for DNA amplification. The primer sequences were as follows: α-SMA (168 bp), 5'-ATAGAACACGGCATCATCACC -3', 5'-GGTCTCAAACATAATCTGGGTCA-3'; BETA-ACTIN (207 BP), 5'-CACCCGCGAGTACAAC CTTC-3', 5'-CCCATACCCACCATCACACC-3'. The PCR reaction conditions were set as follows: pre-denaturation at 95°C for 5 min, 40 cycles of denaturation at 95°C for 15 s, annealing at 56°C for 30 s, and extension at 72°C for 30 s, and a final extension at 72°C for 10 min.
The lower lobe of the left lung, weighing 0.1 g, was washed twice with pre-cooled PBS buffer. Then, 1.5 mL of the protein lysis buffer and 15 µL of the protease inhibitor was added. The cells were scraped off and lysed on ice at 4°C for 20 min. Following centrifugation at 15000 rpm for 15 min, the supernatant was collected and mixed with the loading buffer. The cells were denatured by heating in a 100°C water bath for 5 min. Thirty milligram of protein was collected for each group to perform SDS-PAGE analysis. The proteins were transferred to a nitrocellulose membrane and sealed with 5% defatted milk powder at room temperature for 1 h. The cells were further incubated overnight with primary antibodies at 4°C, followed by incubation with secondary antibodies at room temperature for 1 h. The membranes were developed using an electrochemiluminescent (ECL) solution.
Statistical analysis
All experimental data were expressed as mean ± standard deviation (SD). Thestatistical analyses were performed using SPSS software. Multi-group comparisons were made by ANOVA and P < 0.05 was considered to be statistically significant.
RESULTS
Mean pulmonary arterial pressure and RVHI of rats in each group
The mean pulmonary arterial pressure of rats in the model group was significantly higher than that in the control and intervention groups (P < 0.01). The intervention and control groups also differed in mean pulmonary arterial pressure and RVHI (P < 0.01, Table 1 ).
Morphological observation of pulmonary arterioles
The morphological indicators of pulmonary vessels were compared. We observed an obvious thickening of the walls of the pulmonary vessels, and narrowing of lumens, following MCT treatment for 28 days. The extent of such morphological variations was much lower in the intervention group compared to the MCT group. The endothelial cells of pulmonary vessels showed better continuity in the control group (Table 1 and Figure 1 ). Table 1 . Comparison of mean pulmonary arterial pressure, right ventricular hypertrophy index (RVHI), and morphological indicators of pulmonary vessels between the groups (mean ± SD).
Compared to the other groups, a P < 0.01; compared to the control, b P < 0.01. 
mRNA and protein expressions of α-SMA in lung tissues
The mRNA and protein expressions of α-SMA in the lung tissues were analyzed by RT-PCR, using beta-actin as the internal reference. The results are summarized in Table 2 and Figure  2 . The mRNA expression of α-SMA in the model group was much higher than that in the intervention and control groups (P < 0.01). The intervention group did not differ significantly from the control group in terms of α-SMA mRNA expression in the lung tissues (P < 0.01). The results in Figure 2 were consistent with those in Table 2 .
Compared with other groups, a P < 0.01; compared with the control, b P > 0.05.
Model group 10 4.42 ± 2.05 a Intervention group 10 1.20 ± 0.52 b Control group 10 1 F 24.77 P 0.00 Table 2 . Comparison of relative mRNA expression of α-SMA between the groups (mean ± SD). 
DISCUSSION
PAH is a clinical syndrome featuring right ventricular failure, induced by persistent increase in pulmonary vascular resistance under the impact of a variety of pathogenic factors. Different types of vessels and cytokines in the pulmonary tissues play a key role in the pathogenesis of PAH.
In our study, the PAH model was established in rats using MCT. MCT, a bisbenzylisoquinoline alkaloid, is activated by cytochrome P450 monooxygenase into monocrotalinepyrrole (MCTP), and then transported to the liver by blood circulation. MCT induces hypertrophic pulmonary vasculitis and PAH by effecting a vascular endothelial injury (Stenmark et al., 2005; Kamezaki et al., 2008) . Single injection of MCT leads to hypertrophy of the pulmonary arterial media, PAH, right ventricle (RV) pressure overload, and finally thickening of the RV. Therefore, the PAH model is usually induced by MCT injection in rats (Liang et al., 2010) . We observed a significant rise in mean pulmonary arterial pressure with ventricular hypertrophy 4 weeks after MCT injection, indicating the successful establishment of the PAH model.
Vascular adventitial fibroblasts in resting state can be transformed into myoblasts (MB) under the action of pathogenic factors, which then migrate to the intima and participate in neonatal intima formation. MB features contractility and a special structure, intermediate between that of fibroblasts and smooth muscle cells (Kapanci et al., 1992) . During proliferation, MB synthesizes a large amount of extracellular matrix (ECM). The enhanced secretion of cytokines, growth factors, and inflammatory mediators facilitates the transformation of the fibroblasts into MB, which is involved in pulmonary vascular remodeling. Moreover, α-SMA is a marker of MB. Previous research (Short et al. 2004 ) has shown that hypoxia induces the transformation of fibroblasts into MB by upregulating α-SMA. The active role of α-SMA was also confirmed in PAH.
ATRA, a derivative of vitamin A, inhibits cell proliferation and promotes cell differentiation. Currently, ATRA has been effectively used in anti-cancer treatment strategies (Wiegman et al., 2000) , and against skin diseases caused by epithelial proliferation (Pakala et al., 1995) . Therefore, ATRA has drawn the attention of researchers because of its efficacy in the treatment of vascular obstructive diseases (Braunhut et al., 1994) . So far, very few studies have reported the intervention of pulmonary vascular reconstruction in PAH using ATRA (Qin et al., 2000) .
Our findings indicate that ATRA could inhibit the mRNA and protein expression of α-SMA in MCT-induced PAH. The mean pulmonary arterial pressure was decreased and ventricular hypertrophy was alleviated after 4 weeks of ATRA treatment. Pathological specimens of lung tissues showed the thinned walls and enlarged lumen of the pulmonary arteriole. The WT% and WA% values were significantly decreased in the intervention group compared to the model group. ATRA, at a certain concentration, regulates cell growth, proliferation, differentiation, maturity, and apoptosis (Bushue et al., 2010) . Due to its multiplicity of biological functions, ATRA is widely used to treat tumors and skin diseases; in addition, its effect on the cardiovascular, immune, and nervous systems is currently being explored. Although the role of ATRA in vascular remodeling has been reported in PAH, the precise mechanism of action remains unknown. We discovered that treatment with ATRA was effective against PAH, as it inhibited vascular remodeling by downregulation of α-SMA.
